Phapros Tbk PT
IDX:PEHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Phapros Tbk PT
IDX:PEHA
|
ID |
|
S
|
Supreme Distribution PCL
SET:SPREME
|
TH |
|
E
|
EchoStar Corp
F:E20
|
US |
|
F
|
Futebol Clube do Porto Futebol Sad
ELI:FCP
|
PT |
|
H
|
HORNG SHIUE HOLDING Co Ltd
TWSE:2243
|
KY |
|
Innocan Pharma Corp
F:IP40
|
IL |
|
A
|
Abcellera Biologics Inc
F:8QQ
|
CA |
|
Olympus Corp
F:OLY1
|
JP |
|
W
|
W T K Holdings Bhd
KLSE:WTK
|
MY |
Intrinsic Value
Is PEHA undervalued or overvalued?
See the intrinsic value estimate for Phapros Tbk PT and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
PEHA looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with PEHA’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Phapros Tbk PT Does
Phapros Tbk PT is an Indonesian pharmaceutical company that makes and sells medicines for hospitals, clinics, pharmacies, and wholesalers. Its core business is finished drugs, especially prescription medicines and over-the-counter products that are used for common health needs. It earns money by manufacturing these products and selling them through distributors and healthcare channels.
- Headquarters
- Indonesia ID
- Employees
- 1 485
- IPO date
- Dec 26, 2018
Revenue & Expenses Breakdown
Phapros Tbk PT
Earnings Waterfall
Phapros Tbk PT
The intrinsic value for Phapros Tbk PT (PEHA) under the Base Case is hidden IDR.
Compared with the current market price of 280 IDR, the stock appears hidden.